BAKER BROS CAPITAL GP LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BROS CAPITAL GP LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BROS CAPITAL GP LLC. BAKER BROS CAPITAL GP LLC is 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN).
Latest Insider Trading Transactions of BAKER BROS CAPITAL GP LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, SGEN, GEVA, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 22 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 109.15 | 86,000 | 9,386,900 | 261,000 | |
Apr 22 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 109.15 | 58,000 | 6,330,700 | 175,000 | |
Apr 22 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 10,000 | 25,000 | 629,000 | |
Apr 18 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 15,000 | 37,500 | 619,000 | |
Apr 14 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 109.15 | 117,000 | 12,770,550 | 117,000 | |
Apr 12 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 15,000 | 37,500 | 604,000 | |
Apr 08 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 15,000 | 37,500 | 589,000 | |
Apr 08 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 20,000 | 50,000 | 574,000 | |
Apr 08 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 3,000 | 7,500 | 554,000 | |
Apr 01 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 4.96 | 2,344 | 11,632 | 57,673 | 55.3 K to 57.7 K (+4.24 %) |
Apr 14 2005 | IBPI | Ardea Biosciences, ... | BAKER BROS CAPITAL GP LLC | 10% Owner | Buy | P | 3.57 | 298 | 1,064 | 87,404 | 87.1 K to 87.4 K (+0.34 %) |
Mar 02 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 65,000 | 162,500 | 551,000 | |
Mar 02 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 30,000 | 75,000 | 486,000 | |
Mar 02 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 74,000 | 185,000 | 456,000 | |
Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 30,000 | 75,000 | 382,000 | |
Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 90,000 | 225,000 | 352,000 | |
Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 42,000 | 105,000 | 262,000 | |
Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BROS CAPITAL GP LLC | 10% Owner | Buy | P | 3.02 | 605 | 1,827 | 605 | 0 to 605 |
Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 4.90 | 1,287 | 6,305 | 55,329 | 54 K to 55.3 K (+2.38 %) |
Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 4.81 | 539 | 2,595 | 54,042 | 53.5 K to 54 K (+1.01 %) |
Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 4.90 | 175 | 858 | 53,503 | 53.3 K to 53.5 K (+0.33 %) |
Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 4.96 | 15,443 | 76,590 | 53,328 | 37.9 K to 53.3 K (+40.76 %) |
Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 4.99 | 11 | 55 | 37,885 | 37.9 K to 37.9 K (+0.03 %) |
Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 5.04 | 16,081 | 80,995 | 37,874 | 21.8 K to 37.9 K (+73.79 %) |
Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 4.88 | 1,135 | 5,538 | 21,793 | 20.7 K to 21.8 K (+5.49 %) |
Sep 14 2004 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 13.32 | 4,202 | 55,971 | 331,139 | 326.9 K to 331.1 K (+1.29 %) |
Sep 14 2004 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 13.56 | 3,361 | 45,572 | 326,937 | 323.6 K to 326.9 K (+1.04 %) |
Sep 14 2004 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 12.99 | 273 | 3,547 | 323,576 | 323.3 K to 323.6 K (+0.08 %) |
Sep 14 2004 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 12.55 | 6,303 | 79,126 | 323,303 | 317 K to 323.3 K (+1.99 %) |
Aug 12 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 5.58 | 5,434 | 30,312 | 29,619 | 24.2 K to 29.6 K (+22.47 %) |
Aug 12 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 5.42 | 869 | 4,709 | 24,185 | 23.3 K to 24.2 K (+3.73 %) |
Aug 12 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 5.49 | 180 | 988 | 23,316 | 23.1 K to 23.3 K (+0.78 %) |
Aug 12 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 5.32 | 11,167 | 59,385 | 23,136 | 12 K to 23.1 K (+93.30 %) |
Aug 09 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 5.50 | 849 | 4,670 | 11,969 | 11.1 K to 12 K (+7.63 %) |
Aug 09 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 5.54 | 3,364 | 18,641 | 11,120 | 7.8 K to 11.1 K (+43.37 %) |
Aug 04 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 5.58 | 3,148 | 17,562 | 7,756 | 4.6 K to 7.8 K (+68.32 %) |
Aug 04 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 5.71 | 2,598 | 14,840 | 4,608 | 2 K to 4.6 K (+129.25 %) |
Aug 04 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 5.98 | 1,788 | 10,692 | 2,010 | 222 to 2 K (+805.41 %) |
Aug 04 2004 | SGEN | SEATTLE GENETICS I ... | BAKER BROS CAPITAL GP LLC | Director | Buy | P | 5.89 | 222 | 1,308 | 222 | 0 to 222 |
May 07 2004 | IBPI | Ardea Biosciences, ... | BAKER BROS CAPITAL GP LLC | 10% Owner | Buy | P | 13.00 | 43,396 | 564,148 | 84,828 | 41.4 K to 84.8 K (+104.74 %) |
Mar 17 2004 | IBPI | Ardea Biosciences, ... | BAKER BROS CAPITAL GP LLC | 10% Owner | Buy | P | 16.11 | 852 | 13,729 | 41,300 | 40.4 K to 41.3 K (+2.11 %) |
Page: 1